Adherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.
Ranjani Starr, MPH
Advertisement
Articles by Ranjani Starr, MPH
Advertisement
Latest Updated Articles
- Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic Therapy
Published: September 23rd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Recognizing Immunizing Pharmacists in the Community
5
